| An epithelial–mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor … LA Byers, L Diao, J Wang, P Saintigny, L Girard, M Peyton, L Shen, Y Fan, ... Clinical cancer research 19 (1), 279-290, 2013 | 1003 | 2013 |
| Effect of KRAS Oncogene Substitutions on Protein Behavior: Implications for Signaling and Clinical Outcome NT Ihle, LA Byers, ES Kim, P Saintigny, JJ Lee, GR Blumenschein, A Tsao, ... Journal of the National Cancer Institute 104 (3), 228-239, 2012 | 555 | 2012 |
| Proteomic profiling identifies dysregulated pathways in small cell lung cancer and novel therapeutic targets including PARP1 LA Byers, J Wang, MB Nilsson, J Fujimoto, P Saintigny, J Yordy, U Giri, ... Cancer discovery 2 (9), 798-811, 2012 | 512 | 2012 |
| Genomic and transcriptomic profiling expands precision cancer medicine: the WINTHER trial J Rodon, JC Soria, R Berger, WH Miller, E Rubin, A Kugel, A Tsimberidou, ... Nature medicine 25 (5), 751-758, 2019 | 423 | 2019 |
| New insights into the role of EMT in tumor immune escape S Terry, P Savagner, S Ortiz‐Cuaran, L Mahjoubi, P Saintigny, JP Thiery, ... Molecular oncology 11 (7), 824-846, 2017 | 379 | 2017 |
| miR-200 Inhibits Lung Adenocarcinoma Cell Invasion and Metastasis by Targeting Flt1/VEGFR1 JD Roybal, Y Zang, YH Ahn, Y Yang, DL Gibbons, BN Baird, C Alvarez, ... Molecular cancer research 9 (1), 25-35, 2011 | 231 | 2011 |
| CXCR2 expression in tumor cells is a poor prognostic factor and promotes invasion and metastasis in lung adenocarcinoma P Saintigny, E Massarelli, S Lin, YH Ahn, Y Chen, S Goswami, B Erez, ... Cancer research 73 (2), 571-582, 2013 | 181 | 2013 |
| Recent advances in non-small cell lung cancer biology and clinical management P Saintigny, JA Burger Discovery medicine 13 (71), 287-297, 2012 | 159 | 2012 |
| A stemness-related ZEB1–MSRB3 axis governs cellular pliancy and breast cancer genome stability AP Morel, C Ginestier, RM Pommier, O Cabaud, E Ruiz, J Wicinski, ... Nature medicine 23 (5), 568-578, 2017 | 158 | 2017 |
| Gene expression profiling predicts the development of oral cancer P Saintigny, L Zhang, YH Fan, AK El-Naggar, VA Papadimitrakopoulou, ... Cancer Prevention Research 4 (2), 218-229, 2011 | 157 | 2011 |
| Prognostic and predictive role of CD8 and PD-L1 determination in lung tumor tissue of patients under anti-PD-1 therapy JD Fumet, C Richard, F Ledys, Q Klopfenstein, P Joubert, B Routy, ... British journal of cancer 119 (8), 950-960, 2018 | 149 | 2018 |
| A whole-genome sequence and transcriptome perspective on HER2-positive breast cancers A Ferrari, A Vincent-Salomon, X Pivot, AS Sertier, E Thomas, L Tonon, ... Nature communications 7 (1), 12222, 2016 | 144 | 2016 |
| Epidermal growth factor receptor expression and gene copy number in the risk of oral cancer M Taoudi Benchekroun, P Saintigny, SM Thomas, AK El-Naggar, ... Cancer prevention research 3 (7), 800-809, 2010 | 142 | 2010 |
| Erlotinib and the risk of oral cancer: the erlotinib prevention of oral cancer (EPOC) randomized clinical trial WN William, V Papadimitrakopoulou, JJ Lee, L Mao, EEW Cohen, HY Lin, ... JAMA oncology 2 (2), 209-216, 2016 | 137 | 2016 |
| 6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial X Pivot, G Romieu, M Debled, JY Pierga, P Kerbrat, T Bachelot, ... The Lancet 393 (10191), 2591-2598, 2019 | 130 | 2019 |
| High mortality rate in cancer patients with symptoms of COVID-19 with or without detectable SARS-COV-2 on RT-PCR S Assaad, V Avrillon, ML Fournier, B Mastroianni, B Russias, A Swalduz, ... European Journal of Cancer 135, 251-259, 2020 | 124 | 2020 |
| Epidermal growth factor receptor regulates MET levels and invasiveness through hypoxia-inducible factor-1α in non-small cell lung cancer cells L Xu, MB Nilsson, P Saintigny, T Cascone, MH Herynk, Z Du, ... Oncogene 29 (18), 2616-2627, 2010 | 114 | 2010 |
| Vascular endothelial growth factor-C and its receptor VEGFR-3 in non-small-cell lung cancer: concurrent expression in cancer cells from primary tumour and metastatic lymph node P Saintigny, M Kambouchner, M Ly, N Gomes, O Sainte-Catherine, ... Lung cancer 58 (2), 205-213, 2007 | 113 | 2007 |
| EZH2 promotes malignant behaviors via cell cycle dysregulation and its mRNA level associates with prognosis of patient with non-small cell lung cancer W Cao, RO Ribeiro, D Liu, P Saintigny, R Xia, Y Xue, R Lin, L Mao, H Ren PloS one 7 (12), e52984, 2012 | 88 | 2012 |
| The immune microenvironment of HPV-negative oral squamous cell carcinoma from never-smokers and never-drinkers patients suggests higher clinical benefit of IDO1 and PD1/PD-L1 … JP Foy, C Bertolus, MC Michallet, S Deneuve, R Incitti, ... Annals of Oncology 28 (8), 1934-1941, 2017 | 84 | 2017 |
